bullish
Australian Healthcare: High Growth Ideas for 2022
301 Views03 Jan 2022 00:01
Tina has highlighted this Insight as a Top Pick
SUMMARY
- S&P/ASX 200 gained 14% during 2021, higher than other developed markets in Asia-Pacific. Many healthcare stocks remained resilient to the resurgence of the COVID-19 pandemic and outperformed the broader market.
- Despite the recent surge, Australia’s total infection and deaths numbers are lower than many comparable countries. Australian government has so far ruled out the possibility of lock down.
- In this insight, we have discussed five high growth ideas, with attractive business model and strong growth opportunities. Despite Omicron, these stocks are expected to continue their strong performance.
Get started on the Smartkarma Research Network with a complimentary Preview Pass to:
- Unlock all research summaries
- Follow top, independent analysts
- Receive personalised alerts and emails
- Access Briefings, Analytics, and Events
Upgrade anytime to our paid plans for full-length research, real-time analyst discussions, and more.
Join a thriving community of 45,000+ investors, including the top global asset managers managing over $13trn in assets.
or
Already have an account? Sign In Now
Discussions
(Paid Plans Only)
Top Quartile
Tina Banerjee
Global Healthcare Analyst
- Telix Pharmaceuticals (TLX AU): Illuccix Launched in US; Large Market Opportunity; Potential to Grow15 Aug 2022
- Australia: Underweight & Underowned as Allocations Slip to All-Time Lows.22 Feb 2022
- Telix Pharmaceuticals (TLX AU): Stepping Ahead with First Product Approved in the U.S.09 Jan 2022
- Australian Healthcare: High Growth Ideas for 202203 Jan 2022
x